AAAAAA

   
Results: 1-25 | 26-38
Results: 1-25/38
SERTINDOLE AND DOPAMINE D-2 RECEPTOR OCCUPANCY IN COMPARISON TO RISPERIDONE, CLOZAPINE AND HALOPERIDOL - A I-123 IBZM SPECT STUDY
Authors: KASPER S TAUSCHER J KUFFERLE B BARNAS C HESSELMANN B ASENBAUM S PODREKA I BRUCKE T
Citation: S. Kasper et al., SERTINDOLE AND DOPAMINE D-2 RECEPTOR OCCUPANCY IN COMPARISON TO RISPERIDONE, CLOZAPINE AND HALOPERIDOL - A I-123 IBZM SPECT STUDY, Psychopharmacology, 136(4), 1998, pp. 367-373
NEUROIMAGING IN EUROPEAN ACADEMIC NEUROLOGY - PRESENT STATUS AND FUTURE ORGANIZATION
Authors: BARON JC LENZI GL BRUCKE T FRACKOWIAK R HEISS WD PANTANO P PAULSON OB ROSSINI PM SCHOENEN J TOUBOUL PJ VIONDURY J VONKUMMER R
Citation: Jc. Baron et al., NEUROIMAGING IN EUROPEAN ACADEMIC NEUROLOGY - PRESENT STATUS AND FUTURE ORGANIZATION, European journal of neurology, 5(1), 1998, pp. 5-15
IBZM-SPECT IMAGING OF DOPAMINE D-2 RECEPTORS WITH TYPICAL AND ATYPICAL ANTIPSYCHOTICS
Authors: KASPER S TAUSCHER J KUFFERLE B HESSELMANN B BARNAS C BRUCKE T
Citation: S. Kasper et al., IBZM-SPECT IMAGING OF DOPAMINE D-2 RECEPTORS WITH TYPICAL AND ATYPICAL ANTIPSYCHOTICS, European psychiatry, 13, 1998, pp. 9-14
VISUALIZATION OF DOPAMINE-2 RECEPTOR BLOCKADE IN PSYCHOTIC-PATIENTS TREATED WITH ZOTEPINE
Authors: WILLEIT M BARNAS C TAUSCHER J KUFFERLE B KRENN P ASENBAUM S BRUCKE T KASPER S
Citation: M. Willeit et al., VISUALIZATION OF DOPAMINE-2 RECEPTOR BLOCKADE IN PSYCHOTIC-PATIENTS TREATED WITH ZOTEPINE, Schizophrenia research, 29(1-2), 1998, pp. 204-204
IMAGING THE PRE-SYNAPTIC AND POSTSYNAPTIC SIDE OF STRIATAL DOPAMINERGIC SYNAPSES IN IDIOPATHIC CERVICAL DYSTONIA - A SPECT STUDY USING [I-123] EPIDEPRIDE AND [I-123] BETA-CIT
Authors: NAUMANN M PIRKER W REINERS K LANGE KW BECKER G BRUCKE T
Citation: M. Naumann et al., IMAGING THE PRE-SYNAPTIC AND POSTSYNAPTIC SIDE OF STRIATAL DOPAMINERGIC SYNAPSES IN IDIOPATHIC CERVICAL DYSTONIA - A SPECT STUDY USING [I-123] EPIDEPRIDE AND [I-123] BETA-CIT, Movement disorders, 13(2), 1998, pp. 319-323
IMAGING OF CEREBRAL BLOOD-FLOW WITH TECHNETIUM-99M-HMPAO AND TECHNETIUM-99M-ECD - A COMPARISON
Authors: ASENBAUM S BRUCKE T PIRKER W PIETRZYK U PODREKA I
Citation: S. Asenbaum et al., IMAGING OF CEREBRAL BLOOD-FLOW WITH TECHNETIUM-99M-HMPAO AND TECHNETIUM-99M-ECD - A COMPARISON, The Journal of nuclear medicine, 39(4), 1998, pp. 613-618
BILATERAL CHRONIC ELECTRICAL-STIMULATION OF THE GLOBUS-PALLIDUS INTERNUS FOR THE TREATMENT OF ADVANCED PARKINSONS-DISEASE - A 2-YEAR FOLLOW-UP
Authors: STANDHARDT H PIRKER W BRUCKE T ALESCH F KOOS WT
Citation: H. Standhardt et al., BILATERAL CHRONIC ELECTRICAL-STIMULATION OF THE GLOBUS-PALLIDUS INTERNUS FOR THE TREATMENT OF ADVANCED PARKINSONS-DISEASE - A 2-YEAR FOLLOW-UP, Neurology, 50(4), 1998, pp. 1032-1032
ACUTE PORPHYRIC NEUROPATHY DURING PREGNANCY - EFFECT OF HEMATIN THERAPY
Authors: WENGER S MEISINGER V BRUCKE T DEECKE L
Citation: S. Wenger et al., ACUTE PORPHYRIC NEUROPATHY DURING PREGNANCY - EFFECT OF HEMATIN THERAPY, European neurology, 39(3), 1998, pp. 187-188
IN-VIVO VISUALIZATION OF SEROTONIN TRANSPORTERS DURING TREATMENT WITHSSRI
Authors: TAUSCHER J PIRKER W LENNKH C DEZWAAN M STRNAD A BRUCKE T KASPER S
Citation: J. Tauscher et al., IN-VIVO VISUALIZATION OF SEROTONIN TRANSPORTERS DURING TREATMENT WITHSSRI, Biological psychiatry, 43, 1998, pp. 93-93
ELEVATED BETA-CIT BINDING IN PATIENTS WITH BULIMIA-NERVOSA
Authors: TAUSCHER J PIRKER W LENNKH C DEZWAAN M STRNAD A NEUMEISTER A WILLEIT M PRASCHAKRIEDER N BRUCKE T KASPER S
Citation: J. Tauscher et al., ELEVATED BETA-CIT BINDING IN PATIENTS WITH BULIMIA-NERVOSA, Biological psychiatry, 43, 1998, pp. 94-94
IBZM SPECT IMAGING OF STRIATAL DOPAMINE-2 RECEPTORS IN PSYCHOTIC-PATIENTS TREATED WITH THE NOVEL ANTIPSYCHOTIC SUBSTANCE QUETIAPINE IN COMPARISON TO CLOZAPINE AND HALOPERIDOL
Authors: KUFFERLE B TAUSCHER J ASENBAUM S VESELY C PODREKA I BRUCKE T KASPER S
Citation: B. Kufferle et al., IBZM SPECT IMAGING OF STRIATAL DOPAMINE-2 RECEPTORS IN PSYCHOTIC-PATIENTS TREATED WITH THE NOVEL ANTIPSYCHOTIC SUBSTANCE QUETIAPINE IN COMPARISON TO CLOZAPINE AND HALOPERIDOL, Psychopharmacology, 133(4), 1997, pp. 323-328
PREVIOUS TREATMENT AS A CONFOUNDING VARIABLE IN STUDIES WITH NOVEL ANTIPSYCHOTICS - 2 CASES OF HIGH DOPAMINE-2 RECEPTOR OCCUPANCY WITH QUETIAPINE
Authors: TAUSCHER J KUFFERLE B ASENBAUM S BRUCKE T KASPER S
Citation: J. Tauscher et al., PREVIOUS TREATMENT AS A CONFOUNDING VARIABLE IN STUDIES WITH NOVEL ANTIPSYCHOTICS - 2 CASES OF HIGH DOPAMINE-2 RECEPTOR OCCUPANCY WITH QUETIAPINE, Psychopharmacology, 133(1), 1997, pp. 102-105
OLFACTORY FUNCTIONS IN PARKINSONS-DISEASE AND ALZHEIMERS-DISEASE
Authors: LEHRNER JP BRUCKE T DALBIANCO P GATTERER G KRYSPINEXNER I
Citation: Jp. Lehrner et al., OLFACTORY FUNCTIONS IN PARKINSONS-DISEASE AND ALZHEIMERS-DISEASE, Chemical senses, 22(1), 1997, pp. 105-110
MEASUREMENT OF THE DOPAMINERGIC DEGENERATION IN PARKINSONS-DISEASE WITH [I-123] BETA-CIT AND SPECT - CORRELATION WITH CLINICAL FINDINGS ANDCOMPARISON WITH MULTIPLE SYSTEM ATROPHY AND PROGRESSIVE SUPRANUCLEAR PALSY
Authors: BRUCKE T ASENBAUM S PIRKER W DJAMSHIDIAN S WENGER S WOBER C MULLER C PODREKA I
Citation: T. Brucke et al., MEASUREMENT OF THE DOPAMINERGIC DEGENERATION IN PARKINSONS-DISEASE WITH [I-123] BETA-CIT AND SPECT - CORRELATION WITH CLINICAL FINDINGS ANDCOMPARISON WITH MULTIPLE SYSTEM ATROPHY AND PROGRESSIVE SUPRANUCLEAR PALSY, Journal of neural transmission. Supplementum, (50), 1997, pp. 9-24
IODINE-123-EPIDEPRIDE-SPECT - STUDIES IN PARKINSONS-DISEASE, MULTIPLESYSTEM ATROPHY AND HUNTINGTONS-DISEASE
Authors: PIRKER W ASENBAUM S WENGER S KORNHUBER J ANGELBERGER P DEECKE L PODREKA I BRUCKE T
Citation: W. Pirker et al., IODINE-123-EPIDEPRIDE-SPECT - STUDIES IN PARKINSONS-DISEASE, MULTIPLESYSTEM ATROPHY AND HUNTINGTONS-DISEASE, The Journal of nuclear medicine, 38(11), 1997, pp. 1711-1717
IMAGING OF DOPAMINE TRANSPORTERS WITH IODINE-123-BETA-CIT AND SPECT IN PARKINSONS-DISEASE
Authors: ASENBAUM S BRUCKE T PIRKER W PODREKA I ANGELBERGER P WENGER S WOBER C MULLER C DEECKE L
Citation: S. Asenbaum et al., IMAGING OF DOPAMINE TRANSPORTERS WITH IODINE-123-BETA-CIT AND SPECT IN PARKINSONS-DISEASE, The Journal of nuclear medicine, 38(1), 1997, pp. 1-6
D-2 RECEPTOR OCCUPANCY WITH QUETIAPINE, CLOZAPINE, RISPERIDONE AND HALOPERIDOL
Authors: TAUSCHER J KUFFERLE B BARNAS C ASENBAUM S BRUCKE T KASPER S
Citation: J. Tauscher et al., D-2 RECEPTOR OCCUPANCY WITH QUETIAPINE, CLOZAPINE, RISPERIDONE AND HALOPERIDOL, Biological psychiatry, 41, 1997, pp. 39-39
PREMEDICATION INFLUENCED D-2 RECEPTOR OCCUPANCY WITH QUETIAPINE AND SERTINDOLE
Authors: TAUSCHER J KUFFERLE B BARNAS C ASENBAUM S BRUCKE T KASPER S
Citation: J. Tauscher et al., PREMEDICATION INFLUENCED D-2 RECEPTOR OCCUPANCY WITH QUETIAPINE AND SERTINDOLE, Biological psychiatry, 41, 1997, pp. 40-40
SEROTONIN TRANSPORTER DENSITY IN DEPRESSED SAD PATIENTS
Authors: WILLEIT M PRASCHAKRIEDER N ASENBAUM S NEUMEISTER A HESSELMANN B HABELER A IBATOULLINA E TAUSCHER J PIRKER W BRUCKE T KASPER S
Citation: M. Willeit et al., SEROTONIN TRANSPORTER DENSITY IN DEPRESSED SAD PATIENTS, Biological psychiatry, 41, 1997, pp. 101-101
DOPAMINE D-2 RECEPTOR-BINDING IN TYPICAL AND ATYPICAL NEUROLEPTICS
Authors: KASPER S KUFFERLE B TAUSCHER J ASENBAUM S BARNAS C HESSELMANN B PODREKA I BRUCKE T
Citation: S. Kasper et al., DOPAMINE D-2 RECEPTOR-BINDING IN TYPICAL AND ATYPICAL NEUROLEPTICS, Biological psychiatry, 41, 1997, pp. 227-227
STRIATAL DOPAMINE-2 RECEPTOR OCCUPANCY IN PSYCHOTIC-PATIENTS TREATED WITH RISPERIDONE
Authors: KUFFERLE B BRUCKE T TOPITZSCHRATZBERGER A TAUSCHER J GOSSLER R VESELY C ASENBAUM S PODREKA I KASPER S
Citation: B. Kufferle et al., STRIATAL DOPAMINE-2 RECEPTOR OCCUPANCY IN PSYCHOTIC-PATIENTS TREATED WITH RISPERIDONE, PSYCHIATRY RESEARCH-NEUROIMAGING, 68(1), 1996, pp. 23-30
DOPAMINE D2 RECEPTOR-BINDING IS REDUCED IN WILSONS-DISEASE - CORRELATION OF NEUROLOGICAL DEFICITS WITH STRIATAL I-123 IODOBENZAMIDE BINDING
Authors: ODER W BRUCKE T KOLLEGGER H SPATT J ASENBAUM S DEECKE L
Citation: W. Oder et al., DOPAMINE D2 RECEPTOR-BINDING IS REDUCED IN WILSONS-DISEASE - CORRELATION OF NEUROLOGICAL DEFICITS WITH STRIATAL I-123 IODOBENZAMIDE BINDING, Journal of neural transmission, 103(8-9), 1996, pp. 1093-1103
DOPAMINE D2 RECEPTOR IMAGING IN PITUITARY-ADENOMAS USING IODINE-123-EPIDEPRIDE AND SPECT
Authors: PIRKER W RIEDL M LUGER A CZECH T ROSSLER K ASENBAUM S ANGELBERGER P KORNHUBER J DEECKE L PODREKA I BRUCKE T
Citation: W. Pirker et al., DOPAMINE D2 RECEPTOR IMAGING IN PITUITARY-ADENOMAS USING IODINE-123-EPIDEPRIDE AND SPECT, The Journal of nuclear medicine, 37(12), 1996, pp. 1931-1937
IBZM-SPECT SHOWS LOW STRIATAL D2 BLOCKADE UNDER THERAPY WITH SEROQUEL
Authors: TAUSCHER J KUFFERLE B NEUMEISTER A ASENBAUM S BRUCKE T PODREKA I KASPER S
Citation: J. Tauscher et al., IBZM-SPECT SHOWS LOW STRIATAL D2 BLOCKADE UNDER THERAPY WITH SEROQUEL, Biological psychiatry, 39(7), 1996, pp. 54-54
D2 - RECEPTOR IMAGING (SPECT) AS A TOOL FOR MEASURING THE EFFICACY AND SIDE-EFFECT PROFILE OF TREATMENT WITH NEUROLEPTICS
Authors: KASPER S TAUSCHER J KUFFERLE B HEIDEN A NEUMEISTER A BARNAS C ASENBAUM S PODREKA I BRUCKE T
Citation: S. Kasper et al., D2 - RECEPTOR IMAGING (SPECT) AS A TOOL FOR MEASURING THE EFFICACY AND SIDE-EFFECT PROFILE OF TREATMENT WITH NEUROLEPTICS, Biological psychiatry, 39(7), 1996, pp. 224-224
Risultati: 1-25 | 26-38